Also part of the UPMC family:
Scleroderma, or systemic sclerosis, is a rare autoimmune disease that can cause the connective tissue in the skin — and sometimes the internal organs — to thicken and stiffen.
UPMC has a rich history in the treatment of scleroderma. Our experts have made significant contributions to understanding the epidemiology, clinical and laboratory features, and natural history of this disease.
Specialists at the University of Pittsburgh Simmons Center for Interstitial Lung Disease at UPMC and the Comprehensive Pulmonary Hypertension Program work closely with each other, and with our experts in the UPMC Arthritis and Autoimmunity Center, to help our patients manage the pulmonary complications of systemic sclerosis, which include pulmonary fibrosis and pulmonary hypertension.
We also work closely with esophageal experts in UPMC’s Division of Gastroenterology and the UPMC Heart, Lung, and Esophageal Surgery Institute, because of the high prevalence of esophageal dysmotility, or loss of usual movement, and gastroesophageal reflux (GERD) in people with scleroderma.
There is also a growing body of evidence supporting an association between these esophageal disorders and the development of pulmonary fibrosis.
From our Health Library:
Learn more about the Division of Pulmonary, Allergy, and Critical Care Medicine.
UPMC practices a multidisciplinary, integrated approach to the diagnosis and management of scleroderma.
To determine the best route for treatment, the doctor will:
Diagnosis is based on changes in the skin and, sometimes, your blood vessels and internal organs.
Tests for diagnosing scleroderma may include:
From our Health Library:
Optimal care heavily depends on a team of specialists, whose complementary skills provide each patient with a full range of treatment options for scleroderma.
It's this combination of specialization, complete care, research excellence, and patient support at the University of Pittsburgh Simmons Center for Interstitial Lung Disease, that sets the high standard of care for interstitial lung disease at UPMC.
The UPMC Lung Transplantation Program is nationally renowned. Our experts have performed more than 1,400 lung transplants since the program’s inception.
Doctors at the Simmons Center work closely with members of the Lung Transplant Program to refer patients for evaluation, when the time is right.
At the Simmons Center, we:
From our Health Library:
Your health information, right at your fingertips. Select MyUPMC to access your UPMC health information. For patients of UPMC-affiliated doctors in central Pa., select MyPinnacleHealth.
The portal for all UPMC patients EXCEPT those in Central Pa.
The portal for UPMC patients in Central Pa.